ES8608526A1 - Un procedimiento para preparar nuevos compuestos de cefem - Google Patents

Un procedimiento para preparar nuevos compuestos de cefem

Info

Publication number
ES8608526A1
ES8608526A1 ES534751A ES534751A ES8608526A1 ES 8608526 A1 ES8608526 A1 ES 8608526A1 ES 534751 A ES534751 A ES 534751A ES 534751 A ES534751 A ES 534751A ES 8608526 A1 ES8608526 A1 ES 8608526A1
Authority
ES
Spain
Prior art keywords
preparation
processes
pharmaceutical compositions
compositions containing
cephem compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534751A
Other languages
English (en)
Other versions
ES534751A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838320673A external-priority patent/GB8320673D0/en
Priority claimed from GB838330472A external-priority patent/GB8330472D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8608526A1 publication Critical patent/ES8608526A1/es
Publication of ES534751A0 publication Critical patent/ES534751A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR NUEVOS COMPUESTOS DE CEFEM. COMPRENDE: SOMETER UN COMPUESTO DE FORMULA (II) O SU DERIVADO REACTIVO EN EL GRUPO AMINO O UNA SAL DEL MISMO, A UNA REACCION DE ACILACION CON UN AGENTE ACILANTE DE LA FORMULA R9-OH (DONDE R9 ES ACILO TAL COMO SE HA INDICADO RK) O SU DERIVADO REACTIVO O UNA SAL DEL MISMO, EN UN DISOLVENTE CONVENCIONAL QUE NO AFECTE DE FORMA ADVERSA A LA REACCION, Y A TEMPERATURA AMBIENTE O BAJO ENFRIAMIENTO, PARA OBTENER EL COMPUESTO DE FORMULA (I) O UNA SAL DEL MISMO, EN DONDE RK ES ACILAMINO, R2 ES HIDROGENO, ARILO, UN GRUPO HETEROCICLICO, O CIANO Y R3 ES CARBOXI O CARBOXI PROTEGIDO. SE UTILIZAN PARA TRATAR ENFERMEDADES INFECCIOSAS CAUSADAS POR BACTERIAS PATOGENAS.
ES534751A 1983-08-01 1984-07-31 Un procedimiento para preparar nuevos compuestos de cefem Expired ES8608526A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838320673A GB8320673D0 (en) 1983-08-01 1983-08-01 Cephem compounds
GB838330472A GB8330472D0 (en) 1983-11-15 1983-11-15 Cephem compounds

Publications (2)

Publication Number Publication Date
ES8608526A1 true ES8608526A1 (es) 1986-06-16
ES534751A0 ES534751A0 (es) 1986-06-16

Family

ID=26286725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534751A Expired ES8608526A1 (es) 1983-08-01 1984-07-31 Un procedimiento para preparar nuevos compuestos de cefem

Country Status (10)

Country Link
US (2) US4871730A (es)
EP (2) EP0133678B1 (es)
JP (2) JPH0641473B2 (es)
AT (1) AT385758B (es)
CH (2) CH663790A5 (es)
DE (1) DE3483899D1 (es)
ES (1) ES8608526A1 (es)
FR (1) FR2550200B1 (es)
GB (1) GB2144420B (es)
IT (1) IT1183060B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550200B1 (fr) 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
JPH0653739B2 (ja) * 1984-11-15 1994-07-20 協和醗酵工業株式会社 ３位置換カルバセフエム化合物
US4812562A (en) * 1985-07-25 1989-03-14 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4699981A (en) * 1985-08-12 1987-10-13 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4841044A (en) * 1985-12-23 1989-06-20 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4937332A (en) * 1987-12-25 1990-06-26 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivatives
CA2067230C (en) * 1990-08-09 1996-10-22 Kazuo Sawada Thermocouple
AU3171593A (en) * 1991-12-24 1993-07-28 Taisho Pharmaceutical Co., Ltd. Cephalosporin derivative
WO1994006804A1 (en) * 1992-09-18 1994-03-31 Otsuka Kagaku Kabushiki Kaisha Cephem compound, process for producing the same, and medicine containing the same
AUPN801196A0 (en) * 1996-02-12 1996-03-07 Fujisawa Pharmaceutical Co., Ltd. New cephem compounds and pharmaceutical use thereof
JP2002332288A (ja) * 1997-06-23 2002-11-22 Kyoto Pharmaceutical Industries Ltd セファロスポリン化合物、その用途およびその中間体化合物
US6159706A (en) * 1997-12-23 2000-12-12 Newbiotics, Inc. Application of enzyme prodrugs as anti-infective agents
JP4535530B2 (ja) * 1999-09-20 2010-09-01 大塚化学株式会社 ３−スルホニルオキシ−３−セフェム化合物の製造方法
WO2001083492A1 (en) * 2000-05-02 2001-11-08 Newbiotics, Inc. Improved beta-lactam antibiotics
US7687490B2 (en) * 2005-04-12 2010-03-30 Meiji Seika Kaisha, Ltd. 2-thioethenyl substituted carbapenem derivatives
US20130065874A1 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
CN103588791A (zh) * 2013-11-29 2014-02-19 中国科学院长春应用化学研究所 对硝基苄基-7-苯氧基乙酰胺-3-羟基头孢-4-羧酸酯-1-β-氧化物的制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
GB1377624A (en) * 1972-07-07 1974-12-18 Glaxo Lab Ltd Cephalosporin compounds
CH605997A5 (es) * 1974-08-30 1978-10-13 Ciba Geigy Ag
US3992377A (en) * 1974-12-13 1976-11-16 Eli Lilly And Company 3-Thio-substituted cephalosporin antibiotics
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
ES460952A1 (es) * 1976-07-29 1978-12-01 Hoechst Ag Procedimiento para la preparacion de derivados de cefem.
JPS53103493A (en) * 1977-02-18 1978-09-08 Takeda Chem Ind Ltd Cephalosporin derivatives and process for their preparation
FR2418233A2 (fr) * 1978-02-22 1979-09-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkylthio ou 3-acylamino 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
EP0009008A3 (de) * 1978-09-08 1980-05-14 Ciba-Geigy Ag Cephalosporinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
US4291031A (en) * 1979-02-19 1981-09-22 Fujisawa Pharmaceutical Co., Ltd. 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same
GB2045233B (en) * 1979-03-23 1983-05-11 Erba Farmitalia Unsaturated 3-heterocyclylthiomethyl-7a-methoxy-7-acylamido-3-cephem-4-carboxylic acid derivatives
ZA805312B (en) * 1979-08-28 1981-08-26 Ciba Geigy Polyazathia compounds, processes for the manufacture thereof, pharmaceutical preparations containing such compounds and the use of the latter
US4281117A (en) * 1980-09-04 1981-07-28 Eli Lilly And Company Process for 3-chloro cephalosporin nucleus
GR76342B (es) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co
JPS5888386A (ja) * 1981-10-22 1983-05-26 Fujisawa Pharmaceut Co Ltd セフエム化合物およびその製造法
FR2550200B1 (fr) 1983-08-01 1988-04-08 Fujisawa Pharmaceutical Co Procede de preparation de composes de cephem a activite antimicrobienne et nouveaux produits ainsi obtenus
GB8329030D0 (en) * 1983-10-31 1983-11-30 Fujisawa Pharmaceutical Co Cephem compounds
EP0680094B1 (de) * 1994-04-29 2003-02-26 Shell Solar GmbH Netzunabhängiger elektrischer Energieverbraucher mit zusätzlicher photovoltaischer Stromversorgung

Also Published As

Publication number Publication date
GB8419190D0 (en) 1984-08-30
JPH0641473B2 (ja) 1994-06-01
IT1183060B (it) 1987-10-05
EP0133678B1 (en) 1991-01-09
EP0133678A2 (en) 1985-03-06
AT385758B (de) 1988-05-10
EP0268307A3 (en) 1989-06-28
JPH0543584A (ja) 1993-02-23
FR2550200A1 (fr) 1985-02-08
CH661733A5 (de) 1987-08-14
FR2550200B1 (fr) 1988-04-08
CH663790A5 (de) 1988-01-15
IT8422142A0 (it) 1984-07-31
EP0133678A3 (en) 1986-03-19
GB2144420B (en) 1987-12-09
EP0268307A2 (en) 1988-05-25
US4871730A (en) 1989-10-03
ES534751A0 (es) 1986-06-16
GB2144420A (en) 1985-03-06
DE3483899D1 (de) 1991-02-14
US4985555A (en) 1991-01-15
ATA243884A (de) 1987-10-15
JPS60100585A (ja) 1985-06-04

Similar Documents

Publication Publication Date Title
ES8608526A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
IL89576A0 (en) Peptide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ES8306160A1 (es) "procedimiento para preparar un nuevo compuesto de cefem".
TW369535B (en) A pyrazolopyridine compound and the process for preparing thereof
ES8300112A1 (es) Un procedimiento para preparar compuestos de cefem .
IL86674A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL98872A0 (en) Pyrazolopyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
CA1251209A (en) DISHYDROPYRIDAZINONE DERIVATIVES
ES8107207A1 (es) Procedimiento de preparacion de derivados de tiadiazol
ES8505690A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8307824A1 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES8300774A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
ES8405005A1 (es) Un procedimiento para la preparacion de derivados del acido tetrahidrofurancarboxilico.
ES8800235A1 (es) Un procedimiento para preparar un isomero sin de un compues-to de cefem
ES8607967A1 (es) Un procedimiento para la preparacion de nuevos derivados delacido tiazolilacetico
IL92010A (en) Pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
ES8304923A1 (es) Un procedimiento para la preparacion de un peptido.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8504820A1 (es) Un procedimiento para preparar compuestos de cefem que tienen grupos tiadiazol c isotiazol.
ES8305307A1 (es) Un procedimiento para la preparacion de un aciltripeptido.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980302